Summary
Biogen Idec Inc. (BIIB) filed an 8-K on February 9, 2010, primarily to furnish a press release detailing its financial results for the full year and fourth quarter ended December 31, 2009. The press release, incorporated as Exhibit 99.1, provides key financial and operational performance indicators for the company. Investors should note that this information is furnished, not filed, and therefore not subject to the same liabilities under the Securities Exchange Act of 1934. The filing serves as an official notification to the market of Biogen Idec's reported financial condition and operational outcomes for the period. While the 8-K itself does not contain detailed financial figures, it directs investors to the attached press release for comprehensive data. This typically includes revenue figures, earnings per share, and segment performance, which are crucial for assessing the company's growth trajectory, profitability, and overall financial health. Investors should consult Exhibit 99.1 for specific details on Biogen Idec's performance in late 2009.
Key Highlights
- 1Biogen Idec Inc. (BIIB) announced its full year and fourth quarter 2009 financial results via a press release on February 9, 2010.
- 2The press release is furnished as Exhibit 99.1 to the 8-K filing.
- 3The filing is primarily informational, providing investors with access to the company's reported financial performance.
- 4The reported period covers the twelve months and the three months ending December 31, 2009.
- 5Information provided is furnished and not deemed 'filed' under Section 18 of the Exchange Act.
- 6The filing indicates the company's commitment to timely disclosure of financial results.